Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06792877 · ClinicalTrials.gov registry record · NA

Mindfulness for Cognition in Early-stage Alzheimer's Disease

A NA study of Aging and TBI (Traumatic Brain Injury), sponsored by VA Boston Healthcare System.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06792877: Recruiting NA study of Aging and TBI (Traumatic Brain Injury), sponsored by VA Boston Healthcare System.

NCT06792877 is a NA study of Aging and TBI (Traumatic Brain Injury) that is actively recruiting participants, run by VA Boston Healthcare System. The registered enrollment target is 100 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06792877, a NA study of Aging and TBI (Traumatic Brain Injury), is actively recruiting participants, sponsored by VA Boston Healthcare System.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if mindfulness meditation can improve outcomes in older adults with and without cognitive impairment. The main questions it aims to answer are: 1. How does mindfulness impact thinking and memory? 2. How does mindfulness influence brain function and structure? 3. How does mindfulness affect daily function and quality of life? Researchers will compare all outcomes to one other groups. In one group, individuals will participate in a mindfulness class intervention; in the other group, individuals will not engage in any active interventions immediately, but will be placed on a waitlist for the mindfulness intervention. Researchers will compare all outcomes between the groups groups to determine whether the mindfulness interventions leads to greater improvement compared to no intervention (waitlist group). Participants will: * Be randomly assigned to participate in the mindfulness intervention, or no immediate intervention (waitlist) * Complete paper-and-pencil cognitive testing, surveys, computerized tasks, and neuroimaging measures (EEG and MRI) before and after the intervention Outcomes will be assess at baseline, 2 months, 4 months and 6 months.

Primary Outcome

Paper-and-pencil tests measuring attention, processing speed, and memory.

Interventions

  • BEHAVIORAL Mindfulness Intervention
  • BEHAVIORAL Waitlist then mindfulness

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System - Jamaica Plain Campus - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-01-23
Est. Completion 2027-03-31
Phase NA
VA Boston Healthcare System

17 total trials

What NCT06792877 shows while recruiting

NCT06792877 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower).

The record links to 6 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Intervention is the first listed.

NCT06792877 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06792877 about?

NCT06792877 is a clinical study titled "Mindfulness for Cognition in Early-stage Alzheimer's Disease". The goal of this clinical trial is to learn if mindfulness meditation can improve outcomes in older adults with and without cognitive impairment. The main questions it aims to answer are: 1. How does mindfulness impact thinking and memory? 2. How does mindfulness influence brain function and struct...

What is the current status of trial NCT06792877?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-23. Estimated completion is 2027-03-31.

What conditions does trial NCT06792877 study?

This clinical trial studies the following conditions: Aging, TBI (Traumatic Brain Injury), Mild Cognitive Impairment (MCI), Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease, Healthy Elderly.

What interventions are being tested in trial NCT06792877?

The interventions under investigation include: Mindfulness Intervention (BEHAVIORAL), Waitlist then mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT06792877?

This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06792877 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06792877's enrollment target sits among peer trials

100 87th of 262 higher than 166 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06792877, the US trial registry maintained by the National Library of Medicine. NCT06792877 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.